Beauty Health (NASDAQ:SKIN) Trading Down 1.5% – Should You Sell?
by Teresa Graham · The Cerbat GemShares of The Beauty Health Company (NASDAQ:SKIN – Get Free Report) dropped 1.5% during mid-day trading on Friday . The company traded as low as $0.7446 and last traded at $0.7738. Approximately 1,870,061 shares traded hands during mid-day trading, an increase of 21% from the average daily volume of 1,546,612 shares. The stock had previously closed at $0.7856.
Wall Street Analysts Forecast Growth
SKIN has been the topic of a number of analyst reports. Canaccord Genuity Group decreased their price objective on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Friday, May 1st. Roth Mkm restated a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. Benchmark restated a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th. Finally, TD Cowen cut their target price on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. One investment analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $2.02.
View Our Latest Analysis on SKIN
Beauty Health Price Performance
The business’s 50 day moving average price is $0.85 and its two-hundred day moving average price is $1.16. The stock has a market cap of $100.28 million, a P/E ratio of -4.55 and a beta of 1.12. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37.
Beauty Health (NASDAQ:SKIN – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. The firm had revenue of $64.91 million for the quarter, compared to analyst estimates of $66.28 million. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. As a group, sell-side analysts expect that The Beauty Health Company will post -0.14 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Beauty Health
A number of large investors have recently modified their holdings of SKIN. Invesco Ltd. raised its holdings in shares of Beauty Health by 6.6% during the second quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock valued at $188,000 after purchasing an additional 6,059 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Beauty Health by 5.7% during the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock valued at $299,000 after purchasing an additional 8,142 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Beauty Health by 33.5% during the second quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock valued at $79,000 after purchasing an additional 10,410 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Beauty Health during the third quarter valued at approximately $26,000. Finally, SG Americas Securities LLC raised its holdings in shares of Beauty Health by 111.9% during the fourth quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock valued at $34,000 after purchasing an additional 13,026 shares during the last quarter. Institutional investors own 93.26% of the company’s stock.
About Beauty Health
Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.
Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.